Nontuberculous mycobacteria (NTM) are ubiquitous organisms; their isolation from clinical
specimens does not always indicate clinical disease. The incidence of NTM lung diseases …

The effect of the clinical phenotype of Mycobacterium avium complex (MAC) lung disease on
treatment outcome and redevelopment of nontuberculous mycobacterial (NTM) lung disease …

Background The burden of nontuberculous mycobacterial pulmonary disease (NTM-PD) is
increasing worldwide. Amidst the poor treatment success of antibiotic therapy, adjunctive …

Background The number of patients with nontuberculous mycobacterial pulmonary disease
(NTM-PD) is rapidly increasing globally, especially in the older population. However, there is …

Background Information about the natural history of nontuberculous mycobacterial
pulmonary disease (NTM-PD) is limited. The purpose of this study was to evaluate the long …

Rationale: Patients with refractory Mycobacterium avium complex lung disease (MAC-LD)
undergo long-term macrolide therapy, but macrolide resistance develops infrequently …

Background There are few data regarding the impact of nontuberculous mycobacterial lung
disease (NTM-LD) on lung function during the clinical course of disease. This study aimed to …

Mycobacterium avium complex (MAC) and M. abscessus complex (MABC) comprise the two
most important human pathogen groups causing nontuberculous mycobacterial lung …

Background. Pulmonary resection along with multiple antimicrobial therapy has produced
favorable outcomes at a few centers. However, little is known regarding the risk factors for …

Background: Multidrug therapy is essential for preventing respiratory failure in patients with
highly progressive Mycobacterium avium complex pulmonary disease (MAC-PD). However …